ContraFect_LOGO_Web.jpg
ContraFect Announces Issuance of Composition of Matter Patent for CF-370 by the United States Patent and Trademark Office
May 03, 2021 07:30 ET | ContraFect Corporation
YONKERS, N.Y., May 03, 2021 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a late clinical-stage biotechnology company focused on the discovery and development of direct lytic agents...
ContraFect_LOGO_Web.jpg
ContraFect Corporation Announces Proposed Public Offering of Common Stock
March 17, 2021 16:01 ET | ContraFect Corporation
YONKERS, N.Y., March 17, 2021 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a clinical-stage biotechnology company focused on discovering and developing direct lytic agents for the...
ContraFect_LOGO_Web.jpg
ContraFect Announces up to $18.9 Million in Funding from CARB-X to Support Acceleration of the CF-370 Program for Treating Pseudomonas aeruginosa Infections towards Clinical Stage Development
July 20, 2020 07:30 ET | ContraFect Corporation
YONKERS, N.Y., July 20, 2020 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs),...
Arch Scientist Publishes Data on the Pre-Clinical Efficacy of AB569 in Killing of Drug Resistant Bacteria
February 21, 2020 08:00 ET | Arch Biopartners
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/9328b8b7-9f45-4361-915c-3a569b3716a0 TORONTO, Feb. 21, 2020 (GLOBE NEWSWIRE) --  Arch...
logo.png
Arch Biopartners Announces AB569 Phase I Human Trial Begins Patient Recruitment and Enrollment Stage
February 13, 2018 08:00 ET | Arch Biopartners
TORONTO, Feb. 13, 2018 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (Arch or the Company) (TSX Venture:ARCH) (OTCBB:ACHFF) a portfolio based biotechnology company, announced today the investigator...
gmi logo.jpg
Antimicrobial Coatings Market worth $7bn by 2024: Global Market Insights, Inc.
April 10, 2017 07:30 ET | Global Market Insights, Inc
Ocean View, Delaware, April 10, 2017 (GLOBE NEWSWIRE) -- The research report “Antimicrobial Coatings Market Size By Product (Antimicrobial Powder Coatings [Silver], Surface Modifications and...
Achaogen, Inc.
Achaogen Reports First Quarter 2016 Financial Results
May 05, 2016 16:05 ET | Achaogen, Inc.
-- Accelerated Timeline for Reporting Top-Line Results from Phase 3 EPIC Registration Clinical Trial of Plazomicin; Top-Line Data in First Quarter of 2017 and NDA Submission in Second Half of 2017...
DUX Dental Logo
German Study Finds Bacteria on Seventy Percent of Dental Bib Holders
March 19, 2012 13:43 ET | DUX Dental
OXNARD, Calif., March 19, 2012 (GLOBE NEWSWIRE) -- This week, researchers at the University of Witten/Herdecke in North Rhine-Westphalia, Germany released a clinical study indicating that the...